Table 1 Study population characteristics
From: Quality of Life analysis of patients in chronic use of oral anticoagulant: an observational study
Age range (years) | 22 to 87 |
|---|---|
Female (%) | 62.5 |
Race (%) | |
Black | 48.6 |
White | 20,8 |
Mulatto | 9,7 |
Other | 20,8 |
Education (%) | |
Illiterate | 9.7 |
Incomplete primary education | 45.8 |
Complete primary education | 6.9 |
Incomplete high school | 18.1 |
Complete high school | 18.1 |
Incomplete University course | 1.4 |
Married (%) | 52.8 |
Anticoagulation reason (%) | |
AF | 48.6 |
MHV | 45.8 |
AF and MHV | 5.6 |
Existence of comorbidities (%) | 59.7 |
Use of drugs in addition to an anticoagulant (%) | 98.6 |
Increase the anticoagulant effect | 45.8 |
Decrease the anticoagulant effect | 2.8 |
Anticoagulant (%) | |
Warfarin | 72.2 |
Phenprocoumon | 27.8 |
Treatment length (%) | |
Less than 01 year | 16.7 |
Between 01 to 08 years | 52.8 |
More than 08 years | 26.4 |
Existence of previous bleeding (%) | |
Yes | 37.5 |
No | 62.5 |
Serious Hemorrhage Percentage and slight bleeding/bruise* | |
Slight hemorrhage/bruise | 92,3 |
Serious Hemorrhage | 7,7 |
Hospitalization after treatment with anticoagulant due to complications with anticoagulant or for its dose adjustment. (%)** | |
Yes | 20.8 |
No | 79.2 |
Required emergency care due to anticoagulation (%)** | |
Yes | 38.9 |
No | 61.1 |